Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2012 Dec 4;107(12):2024. doi: 10.1038/bjc.2012.497

Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab

A Gualberto, M L Hixon, D D Karp, D Li, S Green, M Dolled-Filhart, L G Paz-Ares, S Novello, J Blakely, C J Langer, M N Pollak
PMCID: PMC3516686  PMID: 23211971

Retraction to: British Journal of Cancer (2011) 104, 68–74. doi: 10.1038/sj.bjc.6605972

After a thorough review, the corresponding author, Dr Antonio Gualberto, has concluded that the key results reported in this manuscript are incorrect and cannot be reproduced. As there are no remaining samples that would allow a new analysis, he has therefore recommended the retraction of the manuscript to the Editor-in-Chief of BJC.

The co-authors have been informed of this decision.

Dr Gualberto sincerely apologises for any inconvenience this may have caused the readers of the BJC.


Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES